Naropin (Fresenius Kabi USA, LLC)


Welcome to the PulseAid listing for the Naropin drug offered from Fresenius Kabi USA, LLC. This Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Fresenius Kabi USA, LLC
NON-PROPRIETARY NAME: ROPIVACAINE HYDROCHLORIDE
SUBSTANCE NAME: ROPIVACAINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE]
ROUTE: EPIDURAL; PERINEURAL
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2011-05-31
END MARKETING DATE: 0000-00-00


Naropin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNaropin from Fresenius Kabi USA, LLC
LABELER NAME: Fresenius Kabi USA, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 7.5(mg/mL)
START MARKETING DATE: 2011-05-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63323-287_b7de3ae4-ecef-44b0-b20a-7b3a5926d2b9
PRODUCT NDC: 63323-287
APPLICATION NUMBER: NDA020533

Other ROPIVACAINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Ropivacaine Hydrochloride
AuroMedics Pharma LLCRopivacaine Hydrochloride
Fresenius Kabi USA, LLCNaropin
General Injectables & Vaccines, IncNAROPIN
Hospira, Inc.Ropivacaine Hydrochloride
Sagent PharmaceuticalsRopivacaine Hydrochloride
Sandoz IncRopivacaine Hydrochloride